Despite the restrictions on daily life due to the pandemic, 2021 was still a great year for consumer health product marketing, with brands and their agencies devising innovative ways to reach UK consumers. Here we look at HBW Insight's top-10 most read UK marketing stories of 2021, revealing those launches, campaigns and trends which grabbed the attention of readers last year.
Achieving tenth place on our list is Supra Enterprises and its successful relaunch of the Drapolene brand of antiseptic creams.
Shortly after gaining the rights to distribute Drapolene Cream in the UK, Supra repackaged the range – which includes 100g,...
A recently publshed, Bayer-supported, randomized, double-blind study found that functional dyspepsia sufferers using Iberogast reported feeling less full and bloated compared to those on a placebo.
A series of research papers recently published by the Global Self-Care Federation indicate that industry will need to be pragmatic about alternatives to PVC in medicine blister packs.
“Women’s health continues to be ignored, underfunded, and sidelined. Too many women still die from preventable causes or live in poor health. That must change,” says Bill Gates.
HBW Insight speaks to Prime Fifty founder and managing director Max Gowland about the science behind healthy aging and the opportunity for the consumer health industry.
Representing about a fifth of all licensed medicines in the UK, OTCs are considered a critical part of the country's health system, according to a recently published Department of Health and Social Care (DHSC) paper on UK medicines supply issues.
Limits so effective that states are relaxing restrictions they previously set exceeding the nationwide limit Congress imposed in Combat Meth Act in 2006 on the amount of PSE, as well as a second meth precursor, ephedrine, in OTC drugs consumers can purchase daily.
A recently publshed, Bayer-supported, randomized, double-blind study found that functional dyspepsia sufferers using Iberogast reported feeling less full and bloated compared to those on a placebo.
